You have read all your free articles, to continue reading subscribe to read the rest of this content.
Alvotech has announced that its ordinary shares and warrants will begin trading on the Nasdaq Stock Market LLC on Thursday, June 16, under the new ticker symbols “ALVO” and “ALVOW”, respectively. This follows the completion of the company’s business combination with Oaktree Acquisition Already a subscriber Login You have read…
The new name and identity signifies a new phase of growth for the company and the agreement with US-based Regeneron is worth up to 900 million USD. The multi-target license and collaboration agreement with Regeneron includes five distinct programs, three within cancer and two within infectious diAlready a subscriber Login…
The Chinese National Medical Products Administration (NMPA) has approved the oral androgen receptor inhibitor (ARi) darolutamide in combination with docetaxel for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC). Darolutamide is already approved in China for theAlready a subscriber Login You have read all your free articles, to…
Moberg Pharma and Colep have entered a development agreement for MOB-015, a novel topical formulation of terbinafine for onychomycosis (nail fungus). Under the agreement, Colep’s Healthcare Division will share funding by conducting a pharmaceutical development program which will include scale-uAlready a subscriber Login You have read all your free articles,…
